5:51 PM
 | 
Jan 07, 2008
 |  BC Extra  |  Financial News

Emergent gains on preliminary results, guidance

Emergent BioSolutions (NYSE:EBS) gained $1.94 (39%) to $6.93 on Monday after announcing preliminary 2007 financial results and guidance for 2008. Emergent said it expects 2007 revenues...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >